Effect of culture media on in vitro susceptibility testing of fluconazole against some yeasts
- 1 July 1991
- Vol. 34 (7-8) , 319-322
- https://doi.org/10.1111/j.1439-0507.1991.tb00668.x
Abstract
Thirty clinical isolates, comprising six strains of Candida albicans, and four strains each of C. lusitaniae, C. parapsilosis, C. tropicalis, Cryptococcus neoformans, Torulopsis glabrata and Trichosporon beigelii were tested against fluconazole, using Sabouraud's dextrose (SD) broth and a high resolution (HR) medium (Pfizer Central Research, Inc.). The procedure was a standard tube (1 ml/tube) dilution, and C. albicans Y01 09 was included as a reference strain to monitor quality and reproducibility. Results indicated that the minimum inhibitory concentrations (MICs) for all isolates of C. albicans, C. lusitaniae, C. tropicalis, and Tr. beigelii were 100 micrograms ml-1 or greater in the SD medium. In the HR medium, however, the MICs for two isolates of C. albicans were 1.56 micrograms ml-1, in other four gave higher values (greater than 100 micrograms ml-1), and the results for C. lusitaniae and Tr. beigelii were in the range 1.56-3.12 micrograms ml-1. The MICs for C. tropicalis were unaffected (100 micrograms ml-1) by the medium used. All Cr. neoformans isolates yielded a uniform value (1.56 micrograms ml-1) in HR medium as compared to somewhat more variable results (MICs 0.39-1.56 micrograms ml-1) in SD broth. The MICs for T. glabrata in the SD and HR media were 3.12-12.5 and 6.25 micrograms ml-1, respectively. The data indicated that the HR medium is preferable for the in vitro susceptibility testing of C. albicans, C. lusitaniae and Tr. beigelii to fluconazole. The MICs for other yeasts were not affected by the culture medium. The reference C. albicans isolate yielded an MIC of 1.56 micrograms ml-1 throughout.Keywords
This publication has 14 references indexed in Scilit:
- In vitro Susceptibility of 119 Yeast Isolates to Fluconazole, 5-Fluorocytosine, Amphotericin B and KetoconazoleChemotherapy, 1991
- Increased in vitro Sensitivity of Candida albicans to FluconazoleChemotherapy, 1991
- Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeastsAntimicrobial Agents and Chemotherapy, 1990
- FluconazoleDrugs, 1990
- In vitro Susceptibility Testing of Candida Isolates from Clinical Specimens to Four Antifungal AgentsChemotherapy, 1990
- Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patientsThe American Journal of Medicine, 1988
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbitsAntimicrobial Agents and Chemotherapy, 1986
- In vitro studies with miconazole and miconazole nitrateJournal of Antimicrobial Chemotherapy, 1977
- In vitro growth inhibitory studies of phacidin against some dermatophytes, opportunistic and systemic fungi, and yeasts pathogenic on manJournal of Antimicrobial Chemotherapy, 1977